Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in ChinaYunpeng Yang, Li Zhang, Lin Wu et al.|Chinese Clinical Oncology|2020Cited by 8